FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2108979368> ?p ?o ?g. }

• W2108979368 endingPage "1201" @default.
• W2108979368 startingPage "1195" @default.
• W2108979368 abstract "Thiopurines (azathioprine and 6-mercaptopurine) can induce life-threatening myelosuppression. This study determined the frequency, timing, and outcomes of mild and severe myelosuppression after initiation of thiopurine therapy.This retrospective cohort study included patients with inflammatory bowel disease who were new users of thiopurines; those tested for thiopurine methyltransferase levels before therapy were excluded. Patients were followed from their first thiopurine prescription until the earliest of severe leukopenia (white blood cell count, <1.0 x 10(9)/L), severe thrombocytopenia (platelet level, <20 x 10(9)/L), the end of therapy, the first gap in therapy, disenrollment, or December 31, 2006.Among 1997 new users, the incidence of severe leukopenia per 100 person-months was 0.16 (95% confidence interval [CI], 0.03-0.29; n = 6) in weeks 0 to 8, 0.00 in weeks 9 to 24, and 0.01 (95% CI, 0-0.03; n = 3) after week 26 of therapy. The incidence of severe neutropenia and severe thrombocytopenia per 100 person-months during the first 8 weeks of therapy was 0.51 (95% CI, 0.31-0.80; n = 19) and 0.08 (95% CI, 0.02-0.23; n = 3), respectively. During the first 8 weeks, the median duration from a normal white blood cell count to severe leukopenia was 13 days (range, 8-26 d) and to severe neutropenia was 14 days (range, 7-23 d).The high incidence of severe myelosuppression justifies frequent monitoring during the first 8 weeks of therapy. Subsequently, the rate of severe myelosuppression and the proportion of patients who progress from mild to severe myelosuppression decrease, justifying less-frequent monitoring." @default.
• W2108979368 created "2016-06-24" @default.
• W2108979368 creator A5021741152 @default.
• W2108979368 creator A5025708098 @default.
• W2108979368 creator A5026750788 @default.
• W2108979368 creator A5040886662 @default.
• W2108979368 creator A5041936168 @default.
• W2108979368 creator A5048423041 @default.
• W2108979368 creator A5051473333 @default.
• W2108979368 creator A5061269812 @default.
• W2108979368 creator A5067275857 @default.
• W2108979368 date "2009-11-01" @default.
• W2108979368 modified "2023-10-02" @default.
• W2108979368 title "Timing of Myelosuppression During Thiopurine Therapy for Inflammatory Bowel Disease: Implications for Monitoring Recommendations" @default.
• W2108979368 cites W1978270674 @default.
• W2108979368 cites W2013233033 @default.
• W2108979368 cites W2024293518 @default.
• W2108979368 cites W2025343624 @default.
• W2108979368 cites W2038326007 @default.
• W2108979368 cites W2047212658 @default.
• W2108979368 cites W2057925680 @default.
• W2108979368 cites W2058409077 @default.
• W2108979368 cites W2080420604 @default.
• W2108979368 cites W2088315857 @default.
• W2108979368 cites W2090370341 @default.
• W2108979368 cites W2115000032 @default.
• W2108979368 cites W2126280306 @default.
• W2108979368 cites W2145648574 @default.
• W2108979368 cites W2255357183 @default.
• W2108979368 doi "https://doi.org/10.1016/j.cgh.2009.07.019" @default.
• W2108979368 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4435979" @default.
• W2108979368 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19631285" @default.
• W2108979368 hasPublicationYear "2009" @default.
• W2108979368 type Work @default.
• W2108979368 sameAs 2108979368 @default.
• W2108979368 citedByCount "57" @default.
• W2108979368 countsByYear W21089793682012 @default.
• W2108979368 countsByYear W21089793682013 @default.
• W2108979368 countsByYear W21089793682014 @default.
• W2108979368 countsByYear W21089793682015 @default.
• W2108979368 countsByYear W21089793682016 @default.
• W2108979368 countsByYear W21089793682017 @default.
• W2108979368 countsByYear W21089793682018 @default.
• W2108979368 countsByYear W21089793682019 @default.
• W2108979368 countsByYear W21089793682020 @default.
• W2108979368 countsByYear W21089793682021 @default.
• W2108979368 countsByYear W21089793682022 @default.
• W2108979368 countsByYear W21089793682023 @default.
• W2108979368 crossrefType "journal-article" @default.
• W2108979368 hasAuthorship W2108979368A5021741152 @default.
• W2108979368 hasAuthorship W2108979368A5025708098 @default.
• W2108979368 hasAuthorship W2108979368A5026750788 @default.
• W2108979368 hasAuthorship W2108979368A5040886662 @default.
• W2108979368 hasAuthorship W2108979368A5041936168 @default.
• W2108979368 hasAuthorship W2108979368A5048423041 @default.
• W2108979368 hasAuthorship W2108979368A5051473333 @default.
• W2108979368 hasAuthorship W2108979368A5061269812 @default.
• W2108979368 hasAuthorship W2108979368A5067275857 @default.
• W2108979368 hasBestOaLocation W21089793681 @default.
• W2108979368 hasConcept C120665830 @default.
• W2108979368 hasConcept C121332964 @default.
• W2108979368 hasConcept C126322002 @default.
• W2108979368 hasConcept C2776694085 @default.
• W2108979368 hasConcept C2776760755 @default.
• W2108979368 hasConcept C2777063308 @default.
• W2108979368 hasConcept C2778260677 @default.
• W2108979368 hasConcept C2778488018 @default.
• W2108979368 hasConcept C2779134260 @default.
• W2108979368 hasConcept C2780873365 @default.
• W2108979368 hasConcept C61511704 @default.
• W2108979368 hasConcept C70917649 @default.
• W2108979368 hasConcept C71924100 @default.
• W2108979368 hasConcept C74133956 @default.
• W2108979368 hasConcept C90924648 @default.
• W2108979368 hasConceptScore W2108979368C120665830 @default.
• W2108979368 hasConceptScore W2108979368C121332964 @default.
• W2108979368 hasConceptScore W2108979368C126322002 @default.
• W2108979368 hasConceptScore W2108979368C2776694085 @default.
• W2108979368 hasConceptScore W2108979368C2776760755 @default.
• W2108979368 hasConceptScore W2108979368C2777063308 @default.
• W2108979368 hasConceptScore W2108979368C2778260677 @default.
• W2108979368 hasConceptScore W2108979368C2778488018 @default.
• W2108979368 hasConceptScore W2108979368C2779134260 @default.
• W2108979368 hasConceptScore W2108979368C2780873365 @default.
• W2108979368 hasConceptScore W2108979368C61511704 @default.
• W2108979368 hasConceptScore W2108979368C70917649 @default.
• W2108979368 hasConceptScore W2108979368C71924100 @default.
• W2108979368 hasConceptScore W2108979368C74133956 @default.
• W2108979368 hasConceptScore W2108979368C90924648 @default.
• W2108979368 hasIssue "11" @default.
• W2108979368 hasLocation W21089793681 @default.
• W2108979368 hasLocation W21089793682 @default.
• W2108979368 hasLocation W21089793683 @default.
• W2108979368 hasLocation W21089793684 @default.
• W2108979368 hasOpenAccess W2108979368 @default.
• W2108979368 hasPrimaryLocation W21089793681 @default.
• W2108979368 hasRelatedWork W2033088420 @default.
• W2108979368 hasRelatedWork W2040289932 @default.

• next